Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Dose Adjusting Enoxaparin Thromboprophylaxis Dosage According to Anti-factor Xa Plasma Levels Improve Pregnancy Outcome

This study has been completed.
Information provided by (Responsible Party):
Raed Salim, HaEmek Medical Center, Israel Identifier:
First received: January 20, 2010
Last updated: February 20, 2016
Last verified: February 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2015
  Primary Completion Date: January 2015 (Final data collection date for primary outcome measure)